Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany.
作者： Feucht
DOI: 10.2147/OPTH.S2842
关键词:
摘要: Background The VEGF Inhibition Study In Ocular Neovascularisation (VISION) reported the efficacy of intravitreal (ITV) vascular endothelial growth factor (VEGF) inhibition with pegaptanib sodium (Macugen®) for treatment neovascular age-related macular degeneration (AMD). This paper reports clinical experience occult or minimally classic choroidal neovascularization (CNV) due to AMD.
sci-hub.se 参考文章(19)
Wanda S. Lejeune, Clifford C. Stephan, Katherine C. Chang, Joseph R. Williamson, Tommy A. Brock, Ronald G. Tilton, Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Investigative Ophthalmology & Visual Science. ,vol. 40, pp. 689- 696 ,(1999)
A.S. Venkatraman, G.A. Lalwani, C.A. Puliafito, P.J. Rosenfeld, A.E. Fung, S. Michels, Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study Investigative Ophthalmology & Visual Science. ,vol. 47, pp. 2958- 2958 ,(2006)
Daniel W. Drolet, Joyce Nelson, Christopher E. Tucker, Philip M. Zack, Kerry Nixon, Richard Bolin, Mark B. Judkins, James A. Farmer, Julie L. Wolf, Stanley C. Gill, Raymond A. Bendele, Pharmacokinetics and Safety of an Anti-Vascular Endothelial Growth Factor Aptamer (NX1838) Following Injection into the Vitreous Humor of Rhesus Monkeys Pharmaceutical Research. ,vol. 17, pp. 1503- 1510 ,(2000) , 10.1023/A:1007657109012
Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham, Matthew Feinsod, David R. Guyer, Pegaptanib for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 351, pp. 2805- 2816 ,(2004) , 10.1056/NEJMOA042760
RICHARD F. SPAIDE, KETAN LAUD, HOWARD F. FINE, JAMES M. KLANCNIK, CATHERINE B. MEYERLE, LAWRENCE A. YANNUZZI, JOHN SORENSON, JASON SLAKTER, YALE L. FISHER, MICHAEL J. COONEY, Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 383- 390 ,(2006) , 10.1097/01.IAE.0000238561.99283.0E
ANTHONY P. ADAMIS, DAVID T. SHIMA, THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 25, pp. 111- 118 ,(2005) , 10.1097/00006982-200502000-00001
Pascal N. Bernatchez, Simon Rollin, Shay Soker, Martin G. Sirois, Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1 Journal of Cellular Biochemistry. ,vol. 85, pp. 629- 639 ,(2002) , 10.1002/JCB.10155
Stefan Mennel, Josep Callizo, Jörg C. Schmidt, Carsten H. Meyer, Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin™) injections Acta Ophthalmologica Scandinavica. ,vol. 85, pp. 689- 690 ,(2007) , 10.1111/J.1600-0420.2007.00926.X
A Bird, Age-related macular disease. British Journal of Ophthalmology. ,vol. 80, pp. 2- 3 ,(1996) , 10.1136/BJO.80.1.2
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider, None, Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 355, pp. 1432- 1444 ,(2006) , 10.1056/NEJMOA062655